NIH-funded research R37 grant

Gut bacteria and immune responses in alcohol-related liver damage

Official title: Microbiome and Intestinal Innate Immune Response in Alcoholic Liver Disease

Funded at University of California, San Diego · NIH-11123423 · Data updated 2026-11-12

This work looks at how certain gut bacteria and their toxin may worsen liver damage in people who drink heavily.

More Alcoholic Liver Disease research and trials

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startSeptember 25, 2011
Project endJune 30, 2026
Funding year2025
Award (this year)$422,582
NIH project number5R37AA020703-15
Project IDNIH-11123423 on NIH RePORTER

Who could benefit from this research

Could help

Adults with alcohol use disorder or patients diagnosed with alcoholic hepatitis would be the most relevant candidates to participate or benefit.

Less likely to help

People whose liver disease is caused by non-alcohol-related conditions (for example viral, autoimmune, or genetic liver diseases) may not see direct benefits from this work.

What this research studies

This project studies how changes in gut bacteria and a bacterial toxin called cytolysin contribute to alcohol-related liver injury. Researchers combine lab models (mice) with analysis of stool and clinical data from people with alcohol use disorder or alcoholic hepatitis to link the bacteria and toxin to disease severity. The team is examining how alcohol alters gut cell sugars (via FUT2) to allow bacterial overgrowth and how immune clearance (CRIg) handles bacteria that move to the liver. The approach seeks molecular targets in the microbiome and host immune response that could be turned into treatments or diagnostics.

Why it matters

Potential benefit: If successful, the research could lead to ways to reduce harmful gut bacteria or block their toxin, lowering liver injury and deaths from alcoholic hepatitis.

How similar studies have gone: Prior animal experiments and observational studies in patients have linked cytolysin-positive Enterococcus to worse liver outcomes, so this builds on promising preclinical and clinical correlations.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Schnabl, Bernd G. — University of California, San Diego
  • Study coordinator: Schnabl, Bernd G.

Related research

Other NIH-funded projects on the same topics.

  • Microbiome and Innate Immune Response in Alcohol-Related Liver Disease

    Researchers are studying how gut bacteria and the body's first-line immune defenses contribute to liver damage from alcohol, with a focus on how a specific bacteria and its toxins affect disease severity.

    NIH research University of California, San Diego · La Jolla, United States · NIH-11543368

  • Lipotoxicity and Alcohol-Related Liver Disease

    This project studies how fatty acids cause liver cell damage in alcohol-related liver disease to help develop new treatments.

    NIH research University of North Carolina Greensboro · Greensboro, United States · NIH-11450399

  • NNMT as a Target to Treat Alcoholic Liver Disease

    A study to see if blocking an enzyme called NNMT can help people with alcoholic liver disease.

    NIH research University of Illinois at Chicago · Chicago, UNITED STATES · NIH-11380807

  • How gut fungi may drive alcohol-related liver damage

    Researchers are looking at whether specific fungi in the gut make liver damage from heavy drinking worse in people with alcohol-related liver disease.

    NIH research University of California, San Diego · La Jolla, United States · NIH-11378956

  • Heat shock protein 90 and alcohol-related liver disease: how macrophages fuel inflammation

    This project looks at how a cellular stress protein, HSP90, affects liver inflammation in people with alcohol-related liver disease by focusing on macrophages.

    NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11374847

  • Why alcohol-related liver disease can come back after a transplant

    Looking at whether an enzyme called CerS6 helps fat build up in the liver and whether measuring CerS6 can help detect or predict return of alcohol-related liver disease before or after a liver transplant.

    NIH research University of Washington · Seattle, United States · NIH-11329541

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.